J&J Slashes Production of Its Unpopular Covid-19 Shot; Drugmaker ends production contracts and is in arbitration with Merck

After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand.